Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-19

FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA supplemental application approval for Lotronex (alosetron hydrochloride) submitted by Legacy Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTRONEX (alosetron hydrochloride)

Snippet

SUPPL AP for LOTRONEX (ALOSETRON HYDROCHLORIDE)